Creso Pharma share halt for capital raise

Creso Pharma shares have been placed in a trading halt ahead of a capital raising by the Australian medicinal cannabis company.

Creso Pharma shares are in a trading halt ahead of a capital raising by the Miri Halperin-led firm. (AAP)

Creso Pharma shares have been placed in a trading halt ahead of a capital raising announcement by the Australian medicinal cannabis company.

The ASX-listed firm has asked for trade in the shares to be halted until Thursday's market open at the latest.

Shares in Creso Pharma, which aims develop, register and commercialise cannabis and hemp derived products, have tumbled from $1.65 18 months ago to 40.5 cents before the start of trade on Tuesday.